NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR

Tuesday 28 April 2009

Albemarle sees sales decline

Albemarle saw sales in its fine chemicals business fall 18% to $120.8m in Q1 2009. The company attributed the decline to reduced sales in its bromine franchise.
RTT News

No comments: